Explore News By Topic


Study finds upsurge in ‘active surveillance’ for low-risk prostate cancer

Original Press Release Issued by: Dana-Farber Cancer Institute Many men with low-risk prostate cancer who most likely previously would have undergone immediate surgery or radiation are now adopting a more conservative “active surveillance” strategy, according to an analysis of a new federal database by scientists from Dana-Farber Cancer Institute. The use... Read More


Atlanta Hawks, Prostate Cancer Foundation Team Up To Fight Prostate Cancer

ATLANTA – The Atlanta Hawks and Prostate Cancer Foundation (PCF) have joined together to launch a first-of-its-kind multi-pronged program with the goal of slamming prostate cancer. Led by Hawks Vice Chair of the Board and Naismith Memorial Basketball Hall of Famer Grant Hill and his father, NFL Legend Calvin Hill, the Hawks are... Read More


The Prostate Cancer Foundation Kicks Off 2nd Annual TRUE Love Contest With Kristen Bell Honoring Caregivers

LOS ANGELES, Feb. 5, 2019 -- Today, the Prostate Cancer Foundation (PCF) kicks-off its 2nd Annual TRUE Love contest that honors family and caregivers for their tireless work in caring for their loved ones living with prostate cancer. TRUE is a tribute to the unsung heroes – whether they are spouses, partners, nurses, doctors, siblings, children or... Read More


Fuego Box Turns Up The Heat On Prostate Cancer With The Choco Challenge™

LOS ANGELES - JANUARY 31, 2019 As Valentine’s Day approaches, spice up your life while supporting the fight against prostate cancer. Fuego Box, purveyors of small-batch/craft hot sauces delivered to your door monthly, is teaming up with the Prostate Cancer Foundation (PCF) on The Choco Challenge™, the world’s spiciest mini chocolate bar. People... Read More


Prostate Cancer Scoring Method May Underestimate Mortality Risk in Black Men

Original Press Release Issued by: Dana-Farber Cancer Institute Black men diagnosed with prostate cancer classified as low risk may actually have a more aggressive form of the disease that is more likely to be fatal than in nonblack men placed in the same prognostic category, a new study suggests. This... Read More


Reliance on ‘YouTube Medicine’ May Be Dangerous for Those Concerned About Prostate Cancer

Original Press Release Issued by: NYU Langone Health NOVEMBER 27, 2018 (9:30AM) The most popular YouTube videos on prostate cancer often offer misleading or biased medical information that poses potential health risks to patients, an analysis of the social media platform shows. Led by researchers at NYU School of Medicine and NYU... Read More


$2.5 Million Gift From The John And Daria Barry Foundation to the Prostate Cancer Foundation Establishes New Precision Oncology Center of Excellence Serving U.S. Veterans at VA’s Manhattan Campus

NEW YORK, NY, November 8, 2018 – Helping to advance revolutionary research in prostate cancer and delivery of precision treatments to U.S. Veterans, the John and Daria Barry Foundation has donated $2.5 million to the Prostate Cancer Foundation (PCF) to establish the John and Daria Barry Precision Oncology Center of... Read More


The Prostate Cancer Foundation Awards $5.5 Million to PCF Challenge Award Recipients to Advance Prostate Cancer Research

LOS ANGELES, Calif., October 30, 2018 – The Prostate Cancer Foundation (PCF) is announcing today that it will be awarding more than $5.5 million in research funding to six new 2018 PCF Challenge Award teams. Funding for the PCF Challenge Award will support international, multi-institutional, cross-disciplinary teams of scientists conducting... Read More


Baylor research team awarded $6.3 million NCI grant to develop tools to better understand disparities in prostate, breast cancers

Original Press Release Issued by: Baylor College of Medicine HOUSTON – (Oct. 3, 2018) – As part of the Beau Biden Cancer Moonshot initiative, the National Cancer Institute has awarded $6.3 million dollars to Dr. Nicholas Mitsiades and a multidisciplinary, collaborative team at Baylor College of Medicine to establish a... Read More


Clovis Oncology Receives Breakthrough Therapy Designation for Rubraca® (rucaparib) for Treatment of BRCA1/2-Mutated Metastatic Castration Resistant Prostate Cancer (mCRPC)

Breakthrough Therapy designation (BTD) granted to Rubraca based on initial data from ongoingTRITON2 Phase 2 study in advanced prostate cancer The data set from the TRITON2 study which supported BTD will be presented at the 2018 ESMO Congress later this month in Munich    BOULDER, Colo. (BUSINESS WIRE) -- October... Read More